Imrab 1 - 1905.25

23 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

870.0%

Death Rate

Active Ingredients

Imrab 1 - 1905.25

Administration Routes

SubcutaneousUnknown

Species Affected

Dog 18

Cat 5

Most Affected Breeds

Crossbred Canine/dog 3

Chihuahua 2

Poodle - Toy 2

Mixed (Cat) 2

Retriever - Golden 2

Domestic Shorthair 2

Retriever - Labrador 2

Brittany 1

Domestic Longhair 1

Weimaraner 1

Most Reported Reactions

Vomiting 10

Lethargy (see also Central nervous system depression in 'Neurological') 3

Diarrhoea 3

Inappetence 2

Decreased appetite 2

Vocalisation 2

Elevated temperature 2

Drooling 2

Not eating 2

Lethargy (see also Central nervous system depression in Neurological) 2

Elevated serum alkaline phosphatase (ALP) 2

Monocytosis 2

Outcome Breakdown

Outcome Unknown

8 (34.8%)

Recovered/Normal

8 (34.8%)

Ongoing

5 (21.7%)

Euthanized

1 (4.3%)

Died

1 (4.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.